Electrolyte timing strategies that maximize absorption When you take electrolytes matters almost as much as which electrolytes you take
GLP-1 medications are generally prescribed for adults with obesity (BMI 30) or those who are overweight (BMI 27) with related health conditions such as type 2 diabetes, high blood pressure, or high cholesterol
When tested in obese cynomolgus monkeys, treatment with AT-7687 in combination with liraglutide results in lower total energy intake and significant body weight loss compared to placebo but no differences when compared to liraglutide alone
Any haziness developed after initial reconstitution signals bacterial growth or peptide aggregation, both of which make the solution unusable
The results were reassuring: Semaglutide wasnt found in any of the 24 breast milk samples collected at 0, 12, and 24 hours after dose
Sodiumglucose cotransporter-2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) both improve cardiovascular outcomes, but their comparative roles in HF and the potential value of combination therapy remain uncertain